Why the study?
Does a risk stratification score including pre-transplant cardiac troponin T (ACTV score) improve the prediction of all-cause mortality in kidney transplant recipients compared to a score without cTnT?
Population
764 kidney transplant recipients, mean age 58.8 years.
Comparison
Pre-transplant risk stratification using the… vs ACV score.
Design
Cohort
Follow-up
median 7.0 years (range 1 day to 18.0 years)
Authors
Loading...
ACTV score may refine pre-transplant mortality risk assessment in kidney recipients; hypothesis-generating and requires prospective validation before practice change.
Does a risk stratification score including pre-transplant cardiac troponin T (ACTV score) improve the prediction of all-cause mortality in kidney transplant recipients compared to a score without cTnT?
A novel risk score (ACTV) incorporating pre-transplant cardiac troponin T, age, cardiac disease, and vascular disease effectively predicts long-term all-cause mortality in kidney transplant recipients.
Firth et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: